The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study

The effect of treating comorbid depression to achieve optimal management of chronic obstructive pulmonary disease (COPD) has not yet empirically tested. We examined the association between antidepressant treatment and use of and adherence to COPD maintenance medications among patients with new‐onset COPD and comorbid depression.

[1]  Jiaquan Xu,et al.  Deaths: Final Data for 2013. , 2016, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[2]  I. Tsiligianni,et al.  Managing comorbidities in COPD , 2015, International journal of chronic obstructive pulmonary disease.

[3]  G. Alexopoulos,et al.  Pharmacological Treatment of Depression in Older Patients with Chronic Obstructive Pulmonary Disease: Impact on the Course of the Disease and Health Outcomes , 2014, Drugs & Aging.

[4]  D. Au,et al.  Penalizing hospitals for chronic obstructive pulmonary disease readmissions. , 2014, American journal of respiratory and critical care medicine.

[5]  B. Stuart,et al.  Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare Part D population. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[6]  B. Stuart,et al.  Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease , 2014, International journal of geriatric psychiatry.

[7]  P. Langenberg,et al.  Effects of Depression Diagnosis and Antidepressant Treatment on Mortality in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease , 2013, Journal of the American Geriatrics Society.

[8]  T. Doksum,et al.  The role of provider supply and organization in reducing racial/ethnic disparities in mental health care in the U.S. , 2013, Social science & medicine.

[9]  Anand A. Dalal,et al.  Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. , 2012, The American journal of geriatric pharmacotherapy.

[10]  B. Make,et al.  Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients , 2012, International journal of chronic obstructive pulmonary disease.

[11]  Anand A. Dalal,et al.  Clinical and Economic Burden of Depression/Anxiety in Chronic Obstructive Pulmonary Disease Patients within a Managed Care Population , 2011, COPD.

[12]  J. Castelli-Haley,et al.  The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis , 2011, Multiple sclerosis international.

[13]  P. Shekelle,et al.  Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society , 2011, Annals of Internal Medicine.

[14]  Richard A. Goodman,et al.  Managing Multiple Chronic Conditions: A Strategic Framework for Improving Health Outcomes and Quality of Life , 2011, Public health reports.

[15]  L. Akinbami,et al.  Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. , 2011, NCHS data brief.

[16]  A. Swensen,et al.  Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. , 2011, Respiratory medicine.

[17]  M. Toumi,et al.  Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration. , 2010, Clinical therapeutics.

[18]  Anand A. Dalal,et al.  Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. , 2010, The American journal of geriatric pharmacotherapy.

[19]  C. Reynolds,et al.  Predictors of adequate depression treatment among Medicaid-enrolled adults. , 2010, Health services research.

[20]  Anand A. Dalal,et al.  Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population , 2009, Current medical research and opinion.

[21]  J A Anderson,et al.  Adherence to inhaled therapy, mortality and hospital admission in COPD , 2009, Thorax.

[22]  R. Valuck,et al.  Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. , 2009, The Journal of clinical psychiatry.

[23]  M. Brookhart,et al.  Measuring concurrent adherence to multiple related medications. , 2009, The American journal of managed care.

[24]  T. Petty,et al.  Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. , 2009, The American journal of medicine.

[25]  P. Pirraglia,et al.  Effect of depression care on outcomes in COPD patients with depression. , 2009, Chest.

[26]  B. Digiovine,et al.  The Association Between Depressive Symptoms and Acute Exacerbations of COPD , 2009, Lung.

[27]  W. Katon.  The comorbidity of diabetes mellitus and depression. , 2008, The American journal of medicine.

[28]  J. Bourbeau,et al.  Patient adherence in COPD , 2008, Thorax.

[29]  J. Haas,et al.  Race/Ethnicity and Nonadherence to Prescription Medications Among Seniors: Results of a National Study , 2007, Journal of General Internal Medicine.

[30]  J. Avorn,et al.  Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. , 2007, American journal of epidemiology.

[31]  W. Katon,et al.  Impact of antidepressant drug adherence on comorbid medication use and resource utilization. , 2005, Archives of internal medicine.

[32]  Mark E Kunik,et al.  Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. , 2005, Chest.

[33]  Wayne Katon,et al.  Relationship of depression and diabetes self-care, medication adherence, and preventive care. , 2004, Diabetes care.

[34]  D. Cannon,et al.  How well do automated performance measures assess guideline implementation for new-onset depression in the Veterans Health Administration? , 2003, Joint Commission journal on quality and safety.

[35]  A. Yohannes,et al.  A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease † , 2001, International journal of geriatric psychiatry.

[36]  P. Bindels,et al.  Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. , 2001, Journal of clinical epidemiology.

[37]  W. Katon,et al.  Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. , 2000, Archives of internal medicine.

[38]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[39]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[40]  S. McCrone,et al.  Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. , 2009, Heart & lung : the journal of critical care.

[41]  S. Borson,et al.  Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. , 2009, Revista portuguesa de pneumologia.

[42]  Anuja Roy,et al.  Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[43]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[44]  D. Ivanovski,et al.  Printed in U.SA , 1988 .

[45]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.